CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression

CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expressionCUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression, Published online: 17 September 2018; doi:10.1038/s41401-018-0108-5CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression

Source: Acta Pharmacologica Sinica - September 17, 2018 Category: Drugs & Pharmacology Authors: Xu-hong Fu Xiong Zhang Hong Yang Xiao-wei Xu Zong-long Hu Juan Yan Xing-ling Zheng Rong-rui Wei Zhu-qing Zhang Shi-rui Tang Mei-yu Geng Xun Huang Source Type: research